Glucosio E Potassio Cloruro Ii Galenica Senese

Glucosio e Potassio Cloruro II Galenica Senese is an intravenous injection solution that combines potassium chloride and glucose monohydrate. Marketed in the European Union, this prescription‑only product is used by healthcare professionals for electrolyte replacement and energy supplementation during IV therapy. The formulation provides potassium ions to address low serum potassium and glucose to support cellular metabolism, making it suitable in clinical fluid replacement protocols.

Glucosio e Potassio Cloruro II Galenica Senese is indicated for several clinical situations where potassium and carbohydrate support are required.

- Treatment of hypokalemia (low blood potassium) in hospitalized patients. - Supplementation of potassium during intravenous fluid therapy. - Provision of an energy source during peri‑operative or critical‑care IV regimens. - Replacement of electrolytes and calories in patients unable to take oral nutrition. - Support of intracellular potassium shift when combined with insulin therapy.

Adverse reactions to the injection are generally related to the potassium or glucose components and may vary in frequency.

Common: - Mild vein irritation or pain at the infusion site. - Transient hyperglycemia, especially in patients with impaired glucose tolerance. - Slight increase in serum potassium that may cause mild muscle weakness. - Nausea or mild gastrointestinal discomfort. - Local swelling or edema at the injection site. - Minor headache or dizziness.

Serious: - Severe hyperkalemia leading to cardiac arrhythmias. - Anaphylactic or severe allergic reaction to the formulation. - Rapid infusion causing cardiovascular overload or pulmonary edema. - Significant hyperglycemia requiring insulin therapy. - Metabolic acidosis in patients with renal impairment. - Cardiac arrest due to extreme electrolyte disturbance.

Before administering Glucosio e Potassio Cloruro II Galenica Senese, clinicians should evaluate patient-specific factors and monitor relevant parameters.

- Verify serum potassium and glucose levels to avoid over‑correction. - Adjust infusion rate in patients with renal insufficiency or heart failure. - Use caution in individuals with diabetes mellitus or impaired glucose tolerance. - Avoid rapid administration to reduce the risk of cardiac arrhythmias. - Monitor cardiac rhythm and blood pressure during and after infusion. - Consider electrolyte balance when combined with other potassium‑containing solutions.

Glucosio e Potassio Cloruro II Galenica Senese may interact with other medications that affect potassium or glucose homeostasis.

Avoid: - Concurrent use of other potassium supplements or high‑potassium IV fluids. - Co‑administration with potassium‑sparing diuretics (e.g., spironolactone, amiloride). - Simultaneous infusion of hypertonic glucose solutions without glucose monitoring. - Medications that cause hyperkalemia such as trimethoprim.

Use with caution: - Insulin therapy, which can shift potassium intracellularly. - ACE inhibitors or ARBs that may increase serum potassium. - Beta‑blockers that can mask hypoglycemia symptoms. - Loop diuretics that alter electrolyte balance. - Corticosteroids that may raise blood glucose levels. - Antidepressants that may affect electrolyte levels.